Peer-influenced content. Sources you trust. No registration required. This is HCN.
Gut
Lincosamides carried a 31-fold CDI risk and PPIs nearly doubled it in a Swedish analysis of 42,921 cases and 355,159 controls, with corticosteroids, antidepressants, and beta blockers also emerging as independent contributors.
Clinical Pharmacology April 27th 2026
Medical News Today (MNT)
Emerging research suggests vitamin D may influence immune tolerance and gut interactions in IBD, though findings remain exploratory and adjunctive.
Ambulatory Care Nursing April 16th 2026
Gut‑derived blood metabolites distinguished early cognitive impairment from healthy aging in a research cohort, supporting investigation into earlier detection strategies.
Gastroenterology April 15th 2026
Parkinson’s News Today
Repeated fecal transplants improved motor symptoms and constipation in early Parkinson’s, highlighting the gut microbiome as a potential therapeutic research pathway.